Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jul 21, 2016 $127.30 $127.30 $127.30 $127.30 2 172 200
Jul 20, 2016 $126.93 $126.93 $126.93 $126.93 1 817 200
Jul 19, 2016 $124.16 $124.16 $124.16 $124.16 1 426 000
Jul 18, 2016 $125.46 $125.46 $125.46 $125.46 1 003 100
Jul 15, 2016 $125.58 $125.58 $125.58 $125.58 1 606 400
Jul 14, 2016 $125.15 $125.15 $125.15 $125.15 1 317 400
Jul 13, 2016 $123.47 $123.47 $123.47 $123.47 1 594 000
Jul 12, 2016 $125.35 $125.35 $125.35 $125.35 2 412 100
Jul 11, 2016 $125.30 $125.30 $125.30 $125.30 1 734 600
Jul 08, 2016 $124.42 $124.42 $124.42 $124.42 2 447 700
Jul 07, 2016 $123.34 $123.34 $123.34 $123.34 2 812 800
Jul 06, 2016 $121.12 $121.12 $121.12 $121.12 2 723 500
Jul 05, 2016 $117.64 $117.64 $117.64 $117.64 1 442 900
Jul 01, 2016 $118.59 $118.59 $118.59 $118.59 2 561 500
Jun 30, 2016 $116.76 $116.76 $116.76 $116.76 2 562 000
Jun 29, 2016 $114.17 $114.17 $114.17 $114.17 2 718 600
Jun 28, 2016 $114.94 $114.94 $114.94 $114.94 2 358 600
Jun 27, 2016 $111.89 $111.89 $111.89 $111.89 3 282 900
Jun 24, 2016 $112.99 $112.99 $112.99 $112.99 7 514 300
Jun 23, 2016 $123.57 $123.57 $123.57 $123.57 1 922 800
Jun 22, 2016 $121.41 $121.41 $121.41 $121.41 3 681 300
Jun 21, 2016 $124.14 $124.14 $124.14 $124.14 2 691 100
Jun 20, 2016 $123.96 $123.96 $123.96 $123.96 3 473 000
Jun 17, 2016 $125.20 $125.20 $125.20 $125.20 3 526 400
Jun 16, 2016 $127.49 $127.49 $127.49 $127.49 2 189 337
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT